Back
Day Range
$17.26
$18.02
52-Week Range
$3.42
$30.00
Volume
414,749
50D / 200D Avg
$20.20
/
$19.19
Prev Close
$17.62
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.5 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -139.8 | 3.9 |
| Rev Growth 5Y % | 23.0 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$35.60
+105.8%
Low: $16.00
High: $60.00
Forward EPS
-$1.17
Est. Revenue
240 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$6.62
$5.56 – $8.21
|
1 B | 1 |
| FY2029 |
$4.96
$4.16 – $6.15
|
780 M | 1 |
| FY2028 |
$2.17
$0.02 – $3.03
|
550 M | 5 |
Key Takeaways
Revenue grew 22.95% annually over 5 years — strong growth
Negative free cash flow of -162.73M
Capital efficient — spends only 0.26% of revenue on capex
Growth
Revenue Growth (5Y)
22.95%
Revenue (1Y)21.45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-409.69%
Net Margin-139.81%
Op. Margin-113.73%
Safety
Debt / Equity
N/A
Current Ratio4.01
Interest Coverage-3.69
Valuation
P/E Ratio
-5.49
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.45% | Revenue Growth (3Y) | 15.21% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 22.95% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 109.79M | Net Income (TTM) | -153.49M |
| ROE | N/A | ROA | -76.57% |
| Gross Margin | 88.66% | Operating Margin | -113.73% |
| Net Margin | -139.81% | Free Cash Flow (TTM) | -162.73M |
| ROIC | -409.69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.01 |
| Interest Coverage | -3.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.49 | P/B Ratio | N/A |
| P/S Ratio | 7.67 | PEG Ratio | -0.94 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 842.20M | Enterprise Value | 859.79M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 109.79M | 90.40M | 82.71M | 64.36M | 48.04M |
| Net Income | -153.49M | -126.87M | -102.24M | -109.78M | -110.82M |
| EPS (Diluted) | -3.19 | -2.96 | -3.55 | -4.79 | -4.96 |
| Gross Profit | 97.34M | 81.52M | 73.35M | 56.70M | 42.89M |
| Operating Income | -124.86M | -96.78M | -65.54M | -79.04M | -92.29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 200.46M | 285.71M | 178.31M | 135.62M | 119.75M |
| Total Liabilities | 305.93M | 294.51M | 243.52M | 224.98M | 111.33M |
| Shareholders' Equity | -105.47M | -8.80M | -65.21M | -89.36M | 8.41M |
| Total Debt | 128.33M | 123.39M | 99.40M | 99.12M | 398,000.0 |
| Cash & Equivalents | 110.75M | 171.99M | 95.00M | 55.41M | 44.36M |
| Current Assets | 186.02M | 276.14M | 169.19M | 128.91M | 114.39M |
| Current Liabilities | 46.42M | 45.95M | 31.21M | 23.92M | 22.38M |